MYRIAN
ABURTO BARRENECHEA
IRAKASLE ELKARTUA
University of Paris-Sorbonne
París, FranciaUniversity of Paris-Sorbonne-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2020
-
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 5, pp. 453-460